Samsung Biologics Co Ltd (207940) — Working Capital to Net Assets Ratio
Samsung Biologics Co Ltd (207940) has a Working Capital to Net Assets ratio of 21.3% as of September 2025. Working capital of ₩2.59 Trillion (current assets of ₩6.36 Trillion minus current liabilities of ₩3.77 Trillion) is measured against net assets of ₩12.18 Trillion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Samsung Biologics Co Ltd (207940) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Samsung Biologics Co Ltd Working Capital to Net Assets (2014–2024)
This chart shows how Samsung Biologics Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 21.3%, reflecting working capital of ₩2.59 Trillion against net assets of ₩12.18 Trillion KRW. See 207940 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Samsung Biologics Co Ltd (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Samsung Biologics Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 207940 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 15.3% | ₩1.66 Trillion | ₩10.90 Trillion | ₩5.52 Trillion | ₩3.85 Trillion | ▲ +1.4 pp |
| 2023 | 13.9% | ₩1.36 Trillion | ₩9.83 Trillion | ₩5.52 Trillion | ₩4.16 Trillion | ▼ -11.5 pp |
| 2022 | 25.3% | ₩2.28 Trillion | ₩8.98 Trillion | ₩6.46 Trillion | ₩4.18 Trillion | ▼ -9.0 pp |
| 2021 | 34.4% | ₩1.72 Trillion | ₩4.99 Trillion | ₩2.82 Trillion | ₩1.11 Trillion | ▲ +9.1 pp |
| 2020 | 25.3% | ₩1.16 Trillion | ₩4.60 Trillion | ₩1.75 Trillion | ₩589.30 Billion | ▲ +10.0 pp |
| 2019 | 15.3% | ₩665.76 Billion | ₩4.35 Trillion | ₩1.36 Trillion | ₩690.51 Billion | ▼ -5.6 pp |
| 2018 | 20.9% | ₩867.15 Billion | ₩4.16 Trillion | ₩1.58 Trillion | ₩710.53 Billion | ▲ +62.8 pp |
| 2017 | -41.9% | ₩-1.67 Trillion | ₩3.98 Trillion | ₩621.00 Billion | ₩2.29 Trillion | ▼ -17.0 pp |
| 2016 | -24.9% | ₩-1.02 Trillion | ₩4.08 Trillion | ₩1.46 Trillion | ₩2.48 Trillion | ▲ +37.1 pp |
| 2015 | -61.9% | ₩-1.72 Trillion | ₩2.77 Trillion | ₩192.85 Billion | ₩1.91 Trillion | ▼ -58.8 pp |
| 2014 | -3.2% | ₩-19.96 Billion | ₩630.73 Billion | ₩216.84 Billion | ₩236.79 Billion | — |